石大勝華(603026.SH):控股子公司擬投建10萬噸/年液態鋰鹽項目
格隆匯11月7日丨石大勝華(603026.SH)公佈,公司持股51%的子公司勝華新能源擬投資建設10萬噸/年液態鋰鹽項目。項目預計總投資5.6億元人民幣,項目建設地為山東省東營市墾利區同興路198號,佔地面積為50000m2,建設週期為15個月,預計2023年2月份建成投產。
目前勝華新能源主營業務為生產固態六氟磷酸鋰產品,其主營業務佔比100%。 目前勝華新能源沒有液態鋰鹽的生產和銷售業務。基於液態鋰鹽行業發展需求,勝華新能源進行液態鋰鹽項目的建設,有助於強化公司的核心競爭優勢,提升公司盈利能力,為公司長遠發展奠定基礎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.